These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 11979070)
1. Relationship of tumorigenic malignant melanomas to dermal elastin: an expression of tumor/stromal interaction that may be related to prognosis. Feinmesser M; Schachter JM; Tobar A; Sulkes J; Gutman H; Kruk N; Okon E Am J Dermatopathol; 2002 Apr; 24(2):108-17. PubMed ID: 11979070 [TBL] [Abstract][Full Text] [Related]
2. The use of elastin immunostain improves the evaluation of melanomas associated with nevi. Kamino H; Tam S; Tapia B; Toussaint S J Cutan Pathol; 2009 Aug; 36(8):845-52. PubMed ID: 19032378 [TBL] [Abstract][Full Text] [Related]
3. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors. Monteagudo C; Martin JM; Jorda E; Llombart-Bosch A J Clin Pathol; 2007 Jun; 60(6):596-9. PubMed ID: 16522748 [TBL] [Abstract][Full Text] [Related]
10. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas. Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129 [TBL] [Abstract][Full Text] [Related]
11. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin. Karbowniczek M; Chosia M; Domagała W Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein D expression in cutaneous malignant melanoma. Miranda E; Vizoso F; Martín A; Quintela I; Corte MD; Seguí ME; Ordiz I; Merino AM J Surg Oncol; 2003 Jun; 83(2):99-105. PubMed ID: 12772203 [TBL] [Abstract][Full Text] [Related]
13. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728 [TBL] [Abstract][Full Text] [Related]
14. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases. Søndergaard K Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma. Tanabe K; Amoh Y; Kanoh M; Takasu H; Sakai N; Sato Y; Katsuoka K Eur J Dermatol; 2010; 20(3):283-8. PubMed ID: 20156773 [TBL] [Abstract][Full Text] [Related]
16. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas. Wat H; Senthilselvan A; Salopek TG J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815 [TBL] [Abstract][Full Text] [Related]